Intended Use This reagent is intended for in vitro quantitative determination of SGPT in serum or plasma. -IFCC recommended methodology -Linear up to 1000 U/L.
Clinical Significance It is present in most of the tissues, but mainly found in the liver. Increased levels are found in hepatitis, cirrhosis, obstructive jaundice & other hepatic disease. SGPT activity is markedly elevated even before clinical signs of jaundice become apparent in disease associated with hepatic necrosis. Slight elevations are also found in myocardial infraction.
